Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
September 05, 2024
12:00 PM - 01:00 PM EDT
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
Consensus Recommendations for Use of p16/Ki-67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
Consensus Recommendations for Use of p16/Ki-67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
Unlocking the Potential of HER2-Targeted Therapy: Breakthroughs in NSCLC Therapeutic Approaches
Unlocking the Potential of HER2-Targeted Therapy: Breakthroughs in NSCLC Therapeutic Approaches
Unlocking the Potential of HER3-Targeted Therapy: Breakthroughs in EGFR-Mutant NSCLC Therapeutic Approaches
Unlocking the Potential of HER3-Targeted Therapy: Breakthroughs in EGFR-Mutant NSCLC Therapeutic Approaches
Unlocking the Potential of TROP2-Targeted Therapy: Breakthroughs in NSCLC Therapeutic Approaches
Unlocking the Potential of TROP2-Targeted Therapy: Breakthroughs in NSCLC Therapeutic Approaches
The Role of Chemotherapy and Immunotherapy in ROS1-Rearranged NSCLC
The Role of Chemotherapy and Immunotherapy in ROS1-Rearranged NSCLC
Treatment Strategy of ROS1-Rearranged NSCLC in TKI-Naive Patient
Treatment Strategy of ROS1-Rearranged NSCLC in TKI-Naive Patient
Overcoming Acquired TKI-Resistance with Next-generation ROS1-TKI Agents
Overcoming Acquired TKI-Resistance with Next-generation ROS1-TKI Agents
Safety and Tolerability of ROS1 Tyrosine Kinase Inhibitors
Safety and Tolerability of ROS1 Tyrosine Kinase Inhibitors
Current Guidelines and Real-World Evidence for ROS1 Testing in NSCLC
Current Guidelines and Real-World Evidence for ROS1 Testing in NSCLC